| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Kaiser Permanente
| Professional | $393.93 | $947.00 | $2,066.00 | |
Lucent Health
| Facility | $1,269.68 | $4,104.64 | $4,254.29 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the COVID-19 public health emergency
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Kaiser Permanente
| Professional | $393.93 | $947.00 | $2,066.00 | |
Lucent Health
| Facility | $1,269.68 | $4,104.64 | $4,254.29 |